Global Roxithromycin Market Research Report 2024

Publication ID:

PB502242979

Publication Date:

March 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
The global Roxithromycin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Roxithromycin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Roxithromycin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Roxithromycin include Hetero Healthcare, Finecure Pharmaceuticals, Zhejiang Zhenyuan Pharmaceutical, Johnson & Johnson, Hygeia Laboratories, Bayer AG, Allergan, Galderma SA and Valeant Pharmaceutical International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Roxithromycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Roxithromycin.
Report Scope
The Roxithromycin market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Roxithromycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Roxithromycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hetero Healthcare
Finecure Pharmaceuticals
Zhejiang Zhenyuan Pharmaceutical
Johnson & Johnson
Hygeia Laboratories
Bayer AG
Allergan
Galderma SA
Valeant Pharmaceutical International
Stiefel Laboratories
Cipher
Sigma-Aldrich
Hovione
Segment by Type
Roxithromycin Tablets
Roxithromycin Capsules
Roxithromycin Granules
Segment by Application
Respiratory Tract Infections
Urinary Infections
Soft Tissue Infections
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Roxithromycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Roxithromycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Roxithromycin Market Overview
1.1 Product Overview and Scope of Roxithromycin
1.2 Roxithromycin Segment by Type
1.2.1 Global Roxithromycin Market Value Comparison by Type (2024-2030)
1.2.2 Roxithromycin Tablets
1.2.3 Roxithromycin Capsules
1.2.4 Roxithromycin Granules
1.3 Roxithromycin Segment by Application
1.3.1 Global Roxithromycin Market Value by Application: (2024-2030)
1.3.2 Respiratory Tract Infections
1.3.3 Urinary Infections
1.3.4 Soft Tissue Infections
1.4 Global Roxithromycin Market Size Estimates and Forecasts
1.4.1 Global Roxithromycin Revenue 2019-2030
1.4.2 Global Roxithromycin Sales 2019-2030
1.4.3 Global Roxithromycin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Roxithromycin Market Competition by Manufacturers
2.1 Global Roxithromycin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Roxithromycin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Roxithromycin Average Price by Manufacturers (2019-2024)
2.4 Global Roxithromycin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Roxithromycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Roxithromycin, Product Type & Application
2.7 Roxithromycin Market Competitive Situation and Trends
2.7.1 Roxithromycin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Roxithromycin Players Market Share by Revenue
2.7.3 Global Roxithromycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Roxithromycin Retrospective Market Scenario by Region
3.1 Global Roxithromycin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Roxithromycin Global Roxithromycin Sales by Region: 2019-2030
3.2.1 Global Roxithromycin Sales by Region: 2019-2024
3.2.2 Global Roxithromycin Sales by Region: 2025-2030
3.3 Global Roxithromycin Global Roxithromycin Revenue by Region: 2019-2030
3.3.1 Global Roxithromycin Revenue by Region: 2019-2024
3.3.2 Global Roxithromycin Revenue by Region: 2025-2030
3.4 North America Roxithromycin Market Facts & Figures by Country
3.4.1 North America Roxithromycin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Roxithromycin Sales by Country (2019-2030)
3.4.3 North America Roxithromycin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Roxithromycin Market Facts & Figures by Country
3.5.1 Europe Roxithromycin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Roxithromycin Sales by Country (2019-2030)
3.5.3 Europe Roxithromycin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Roxithromycin Market Facts & Figures by Country
3.6.1 Asia Pacific Roxithromycin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Roxithromycin Sales by Country (2019-2030)
3.6.3 Asia Pacific Roxithromycin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Roxithromycin Market Facts & Figures by Country
3.7.1 Latin America Roxithromycin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Roxithromycin Sales by Country (2019-2030)
3.7.3 Latin America Roxithromycin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Roxithromycin Market Facts & Figures by Country
3.8.1 Middle East and Africa Roxithromycin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Roxithromycin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Roxithromycin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Roxithromycin Sales by Type (2019-2030)
4.1.1 Global Roxithromycin Sales by Type (2019-2024)
4.1.2 Global Roxithromycin Sales by Type (2025-2030)
4.1.3 Global Roxithromycin Sales Market Share by Type (2019-2030)
4.2 Global Roxithromycin Revenue by Type (2019-2030)
4.2.1 Global Roxithromycin Revenue by Type (2019-2024)
4.2.2 Global Roxithromycin Revenue by Type (2025-2030)
4.2.3 Global Roxithromycin Revenue Market Share by Type (2019-2030)
4.3 Global Roxithromycin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Roxithromycin Sales by Application (2019-2030)
5.1.1 Global Roxithromycin Sales by Application (2019-2024)
5.1.2 Global Roxithromycin Sales by Application (2025-2030)
5.1.3 Global Roxithromycin Sales Market Share by Application (2019-2030)
5.2 Global Roxithromycin Revenue by Application (2019-2030)
5.2.1 Global Roxithromycin Revenue by Application (2019-2024)
5.2.2 Global Roxithromycin Revenue by Application (2025-2030)
5.2.3 Global Roxithromycin Revenue Market Share by Application (2019-2030)
5.3 Global Roxithromycin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hetero Healthcare
6.1.1 Hetero Healthcare Corporation Information
6.1.2 Hetero Healthcare Description and Business Overview
6.1.3 Hetero Healthcare Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hetero Healthcare Roxithromycin Product Portfolio
6.1.5 Hetero Healthcare Recent Developments/Updates
6.2 Finecure Pharmaceuticals
6.2.1 Finecure Pharmaceuticals Corporation Information
6.2.2 Finecure Pharmaceuticals Description and Business Overview
6.2.3 Finecure Pharmaceuticals Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Finecure Pharmaceuticals Roxithromycin Product Portfolio
6.2.5 Finecure Pharmaceuticals Recent Developments/Updates
6.3 Zhejiang Zhenyuan Pharmaceutical
6.3.1 Zhejiang Zhenyuan Pharmaceutical Corporation Information
6.3.2 Zhejiang Zhenyuan Pharmaceutical Description and Business Overview
6.3.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Product Portfolio
6.3.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Roxithromycin Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Hygeia Laboratories
6.5.1 Hygeia Laboratories Corporation Information
6.5.2 Hygeia Laboratories Description and Business Overview
6.5.3 Hygeia Laboratories Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hygeia Laboratories Roxithromycin Product Portfolio
6.5.5 Hygeia Laboratories Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer AG Roxithromycin Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Roxithromycin Product Portfolio
6.7.5 Allergan Recent Developments/Updates
6.8 Galderma SA
6.8.1 Galderma SA Corporation Information
6.8.2 Galderma SA Description and Business Overview
6.8.3 Galderma SA Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Galderma SA Roxithromycin Product Portfolio
6.8.5 Galderma SA Recent Developments/Updates
6.9 Valeant Pharmaceutical International
6.9.1 Valeant Pharmaceutical International Corporation Information
6.9.2 Valeant Pharmaceutical International Description and Business Overview
6.9.3 Valeant Pharmaceutical International Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Valeant Pharmaceutical International Roxithromycin Product Portfolio
6.9.5 Valeant Pharmaceutical International Recent Developments/Updates
6.10 Stiefel Laboratories
6.10.1 Stiefel Laboratories Corporation Information
6.10.2 Stiefel Laboratories Description and Business Overview
6.10.3 Stiefel Laboratories Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Stiefel Laboratories Roxithromycin Product Portfolio
6.10.5 Stiefel Laboratories Recent Developments/Updates
6.11 Cipher
6.11.1 Cipher Corporation Information
6.11.2 Cipher Roxithromycin Description and Business Overview
6.11.3 Cipher Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipher Roxithromycin Product Portfolio
6.11.5 Cipher Recent Developments/Updates
6.12 Sigma-Aldrich
6.12.1 Sigma-Aldrich Corporation Information
6.12.2 Sigma-Aldrich Roxithromycin Description and Business Overview
6.12.3 Sigma-Aldrich Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sigma-Aldrich Roxithromycin Product Portfolio
6.12.5 Sigma-Aldrich Recent Developments/Updates
6.13 Hovione
6.13.1 Hovione Corporation Information
6.13.2 Hovione Roxithromycin Description and Business Overview
6.13.3 Hovione Roxithromycin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hovione Roxithromycin Product Portfolio
6.13.5 Hovione Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Roxithromycin Industry Chain Analysis
7.2 Roxithromycin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Roxithromycin Production Mode & Process
7.4 Roxithromycin Sales and Marketing
7.4.1 Roxithromycin Sales Channels
7.4.2 Roxithromycin Distributors
7.5 Roxithromycin Customers
8 Roxithromycin Market Dynamics
8.1 Roxithromycin Industry Trends
8.2 Roxithromycin Market Drivers
8.3 Roxithromycin Market Challenges
8.4 Roxithromycin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Hetero Healthcare
Finecure Pharmaceuticals
Zhejiang Zhenyuan Pharmaceutical
Johnson & Johnson
Hygeia Laboratories
Bayer AG
Allergan
Galderma SA
Valeant Pharmaceutical International
Stiefel Laboratories
Cipher
Sigma-Aldrich
Hovione

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂